One problem: There may be warnings about cardiac and other side effects on the drug's label, although Iannini thinks these worries have been largely dispelled.
According to Paul Iannini Paul Iannini , chairman of the department of medicine at Danbury Hospital and clinical professor of medicine at Yale University School of Medicine, the bacteria figured out how to get around the macrolides in two ways.